The Pharmaceutical Intellectual Property and Competition – Christopher Weber and Dr Benjamin Pesch publish on recent developments in intellectual property and competition law in the pharmaceutical sector in Germany

The Pharmaceutical Intellectual Property and Competition, now in its 5th edition, rovides a practical overview of pharmaceutical intellectual property issues, including the nexus of patents, exclusivity rights and related competition issues.

With a focus on current developments, the guide serves as a valuable tool for managing global risks in this field – analysing key legal and regulatory aspects in major jurisdictions worldwide.

Our team of authors, Christopher Weber and Dr Benjamin Pesch, have again written the German chapter in this year’s edition, which covers the principles and current developments of intellectual property and competition law in the German pharmaceutical sector.

“The Pharmaceutical Intellectual Property and Competition” is published this year on  Lexology, the exclusive platform for all The Law Reviews publications.

Read the editor’s foreword here.

Christoper Weber and Dr Benjamin Pesch will be pleased to answer any detailed questions you may have.